DIG
IOBT

Dauntless Investment Group’s IO Biotech IOBT Stock Holding History

Dauntless Investment Group’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-451,641
Closed -$275K – 83
2025
Q4 		$275K Buy
+451,641
New +$336K 0.22% 46
2025
Q3 		– Sell
-324,389
Closed -$451K – 88
2025
Q2 		$451K Sell
324,389
-357,057
-52% -$409K 0.78% 24
2025
Q1 		$743K Sell
681,446
-66,200
-9% -$62.5K 0.87% 22
2024
Q4 		$688K Buy
+747,646
New +$744K 0.72% 21

Other funds holding IOBT

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

Dauntless Investment Group's IOBT Position: Q1 2026 in Review

Dauntless Investment Group sold out of IO Biotech (IOBT) in Q1 2026, closing a stake of 451,641 shares — an estimated $275K sold.

Dauntless Investment Group first reported a position in IOBT in Q4 2024 and held it in 4 quarters. The position peaked at $743K in Q1 2025. 12 funds tracked by Wall St. Rank hold IOBT as of Q1 2026.

  • Dauntless Investment Group reported no remaining IO Biotech position as of Q1 2026 after selling out during the quarter.
  • Dauntless Investment Group sold 451,641 IO Biotech shares in Q1 2026, an estimated $275K.
  • Dauntless Investment Group first reported a position in IO Biotech in Q4 2024 and held it in 4 quarters.
  • Dauntless Investment Group's IO Biotech position peaked at $743K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held IO Biotech as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.